Antipsychotic Drug Reduction

In recent years, there has been much talk about drug reduction in nursing homes. We hear about “GDR meetings” and even a new verb, as in “We are ‘GDRing’ our residents’ medications.” ...

Veterans nursing homes have made significant strides in reducing antipsychotic medication use, a new analysis shows. The decrease, however, may be contributing to the use of more alternative medications.

The findings raise questions about the short- and long-term effects on the quality of care and health outcomes for residents, the authors say.

Antipsychotic reduction in long-term care facilities likely results in significant unintended fallout, new data from Canada show. The results mirror those of similar studies in the United States, with...

The increased odds of experiencing a stroke within 60 days of starting treatment suggests that even short-term antipsychotic use should be avoided if possible, investigators contend.

Wards with trained nurses showed a significant reduction in psychotropic drug use and drug costs. Maintenance strategies may be needed, however, as the improvements had waned by 12 months, researchers...

As antipsychotic stewardship backslides in nursing homes, risks mount … Don’t pause osteoporosis drug risedronate for more than two years, new research suggests … CDC advisers plan review of more...

The Minimum Data Set should not be CMS’ sole source for determining the number of nursing home residents using antipsychotic drugs, according to a new report from HHS’ Office of the Inspector General.

Training and support leads to discontinuation of antipsychotic meds in residents who do not have a diagnosis of psychosis or mental health issues, researchers have found. Notably, behavioral symptoms did...

Assisted living quality initiatives will focus on increasing satisfaction while reducing turnover, re-admissions and antipsychotics use, the National Center for Assisted Living announced on Tuesday.